tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten

C65H89N15O14W2 — CID 158954699

IUPACtert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten
SMILESC.CN(C(=O)OC(C)(C)C)C1CN(Cc2cccc3c2n(C)c(=O)n3C2CCC(=O)NC2=O)C1.CN(C(=O)OC(C)(C)C)C1CNC1.CNC1CN(Cc2cccc3c2n(C)c(=O)n3C2CCC(=O)NC2=O)C1.Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(C=O)c21.[W].[W]
InChIInChI=1S/C23H31N5O5.C18H23N5O3.C14H13N3O4.C9H18N2O2.CH4.2W/c1-23(2,3)33-22(32)25(4)15-12-27(13-15)11-14-7-6-8-16-19(14)26(5)21(31)28(16)17-9-10-18(29)24-20(17)30;1-19-12-9-22(10-12)8-11-4-3-5-13-16(11)21(2)18(26)23(13)14-6-7-15(24)20-17(14)25;1-16-12-8(7-18)3-2-4-9(12)17(14(16)21)10-5-6-11(19)15-13(10)20;1-9(2,3)13-8(12)11(4)7-5-10-6-7;;;/h6-8,15,17H,9-13H2,1-5H3,(H,24,29,30);3-5,12,14,19H,6-10H2,1-2H3,(H,20,24,25);2-4,7,10H,5-6H2,1H3,(H,15,19,20);7,10H,5-6H2,1-4H3;1H4;;
InChIKeyJLWBFCMFRUDIQI-UHFFFAOYSA-N
MW1672.20 g/mol
LogP2.68
Rot. Bonds11

About tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten

tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten (PubChem CID 158954699) has the molecular formula C65H89N15O14W2 and a molecular weight of 1672.20 g/mol. Its IUPAC name is tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten.

Molecular Properties

Compound Nametert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten
PubChem CID158954699
Molecular FormulaC65H89N15O14W2
Molecular Weight1672.20 g/mol
Exact Mass1671.57
IUPAC Nametert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten
SMILESC.CN(C(=O)OC(C)(C)C)C1CN(Cc2cccc3c2n(C)c(=O)n3C2CCC(=O)NC2=O)C1.CN(C(=O)OC(C)(C)C)C1CNC1.CNC1CN(Cc2cccc3c2n(C)c(=O)n3C2CCC(=O)NC2=O)C1.Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(C=O)c21.[W].[W]
InChIInChI=1S/C23H31N5O5.C18H23N5O3.C14H13N3O4.C9H18N2O2.CH4.2W/c1-23(2,3)33-22(32)25(4)15-12-27(13-15)11-14-7-6-8-16-19(14)26(5)21(31)28(16)17-9-10-18(29)24-20(17)30;1-19-12-9-22(10-12)8-11-4-3-5-13-16(11)21(2)18(26)23(13)14-6-7-15(24)20-17(14)25;1-16-12-8(7-18)3-2-4-9(12)17(14(16)21)10-5-6-11(19)15-13(10)20;1-9(2,3)13-8(12)11(4)7-5-10-6-7;;;/h6-8,15,17H,9-13H2,1-5H3,(H,24,29,30);3-5,12,14,19H,6-10H2,1-2H3,(H,20,24,25);2-4,7,10H,5-6H2,1H3,(H,15,19,20);7,10H,5-6H2,1-4H3;1H4;;
InChIKeyJLWBFCMFRUDIQI-UHFFFAOYSA-N
XLogP2.68
TPSA325.99 Ų
H-Bond Donors5
H-Bond Acceptors24
Rotatable Bonds11
Heavy Atoms96
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001672.20
LogP ≤ 52.68
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten?
The IUPAC name of tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten (CID 158954699) is tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten.
What is the SMILES notation for tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten?
The canonical SMILES for tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten is C.CN(C(=O)OC(C)(C)C)C1CN(Cc2cccc3c2n(C)c(=O)n3C2CCC(=O)NC2=O)C1.CN(C(=O)OC(C)(C)C)C1CNC1.CNC1CN(Cc2cccc3c2n(C)c(=O)n3C2CCC(=O)NC2=O)C1.Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(C=O)c21.[W].[W].
What is the InChIKey of tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten?
The InChIKey is JLWBFCMFRUDIQI-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H31N5O5.C18H23N5O3.C14H13N3O4.C9H18N2O2.CH4.2W/c1-23(2,3)33-22(32)25(4)15-12-27(13-15)11-14-7-6-8-16-19(14)26(5)21(31)28(16)17-9-10-18(29)24-20(17)30;1-19-12-9-22(10-12)8-11-4-3-5-13-16(11)21(2)18(26)23(13)14-6-7-15(24)20-17(14)25;1-16-12-8(7-18)3-2-4-9(12)17(14(16)21)10-5-6-11(19)15-13(10)20;1-9(2,3)13-8(12)11(4)7-5-10-6-7;;;/h6-8,15,17H,9-13H2,1-5H3,(H,24,29,30);3-5,12,14,19H,6-10H2,1-2H3,(H,20,24,25);2-4,7,10H,5-6H2,1H3,(H,15,19,20);7,10H,5-6H2,1-4H3;1H4;;.
What are the key properties of tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten?
tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten has a molecular weight of 1672.20 g/mol, XLogP of 2.68, 11 rotatable bonds, 5 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl N-(azetidin-3-yl)-N-methylcarbamate;tert-butyl N-[1-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]methyl]azetidin-3-yl]-N-methylcarbamate;1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazole-4-carbaldehyde;methane;3-[3-methyl-4-[[3-(methylamino)azetidin-1-yl]methyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;tungsten is sourced from PubChem (CID 158954699), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).